Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Tretinoin 0.04% Microsphere Gel vs Retin-A Micro in Acne
NCT01243450Phase 3Completed
- Sponsor
- Spear Pharmaceuticals
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in acne vulgaris, sponsored by Spear Pharmaceuticals. Started Oct 2009; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01243450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243450.